US Stock MarketDetailed Quotes

ARTL Artelo Biosciences

Watchlist
  • 1.2800
  • +0.0300+2.40%
Close Aug 23 16:00 ET
  • 1.2800
  • 0.00000.00%
Post 20:02 ET
4.13MMarket Cap-382P/E (TTM)

Artelo Biosciences Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
40.81%2.51M
12.96%2.59M
-3.47%9.93M
-6.79%3.24M
9.19%2.61M
-27.80%1.78M
17.78%2.29M
154.50%10.29M
84.22%3.48M
6.33%2.39M
Selling and administrative expenses
-19.86%827K
2.37%1.08M
-29.00%4.23M
-36.23%1.12M
-21.81%1.03M
-27.07%1.03M
-28.68%1.06M
184.22%5.96M
37.64%1.75M
1.21%1.32M
-General and administrative expense
-19.86%827K
2.37%1.08M
-29.00%4.23M
-36.23%1.12M
-21.81%1.03M
-27.07%1.03M
-28.68%1.06M
184.22%5.96M
37.64%1.75M
1.21%1.32M
Research and development costs
124.07%1.69M
22.02%1.51M
31.73%5.7M
23.06%2.12M
47.03%1.59M
-28.79%752K
166.16%1.24M
122.43%4.32M
180.44%1.73M
13.33%1.08M
Operating profit
-40.81%-2.51M
-12.96%-2.59M
3.47%-9.93M
6.79%-3.24M
-9.19%-2.61M
27.80%-1.78M
-17.78%-2.29M
-154.50%-10.29M
-84.22%-3.48M
-6.33%-2.39M
Net non-operating interest income expense
0
0
0
-400.00%-3K
0
-886.16%-5K
Non-operating interest income
----
----
--0
--0
--0
----
----
100.00%2K
--0
--0
Non-operating interest expense
----
----
--0
--0
--0
----
----
--5K
--0
--5K
Other net income (expense)
-57.30%79K
-14.52%106K
209.66%641K
21.90%167K
139.13%165K
780.95%185K
720.00%124K
3,350.00%207K
43,046.71%137K
6,912.20%69K
Gain on sale of security
-57.30%79K
-14.52%106K
209.66%641K
21.90%167K
139.13%165K
780.95%185K
720.00%124K
3,350.00%207K
43,046.71%137K
6,912.20%69K
Income before tax
-52.16%-2.43M
-14.53%-2.48M
7.87%-9.29M
7.97%-3.07M
-5.11%-2.45M
34.71%-1.6M
-10.33%-2.17M
-149.89%-10.08M
-76.98%-3.34M
-3.57%-2.33M
Income tax
0
0
0
0
0
0
0
0
0
0
Net income
-52.16%-2.43M
-14.53%-2.48M
7.87%-9.29M
7.97%-3.07M
-5.11%-2.45M
34.71%-1.6M
-10.33%-2.17M
-149.89%-10.08M
-76.98%-3.34M
-3.57%-2.33M
Net income continuous Operations
-52.16%-2.43M
-14.53%-2.48M
7.87%-9.29M
7.97%-3.07M
-5.11%-2.45M
34.71%-1.6M
-10.33%-2.17M
-149.89%-10.08M
-76.98%-3.34M
-3.57%-2.33M
Minority interest income
Net income attributable to the parent company
-52.16%-2.43M
-14.53%-2.48M
7.87%-9.29M
7.97%-3.07M
-5.11%-2.45M
34.71%-1.6M
-10.33%-2.17M
-149.89%-10.08M
-76.98%-3.34M
-3.57%-2.33M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-52.16%-2.43M
-14.53%-2.48M
7.87%-9.29M
7.97%-3.07M
-5.11%-2.45M
34.71%-1.6M
-10.33%-2.17M
-149.89%-10.08M
-76.98%-3.34M
-3.57%-2.33M
Basic earnings per share
-33.93%-0.75
-2.63%-0.78
11.80%-3.14
16.10%-0.99
-1.22%-0.83
35.63%-0.56
-8.57%-0.76
-96.69%-3.56
-15.69%-1.18
45.33%-0.82
Diluted earnings per share
-33.93%-0.75
-2.63%-0.78
11.80%-3.14
16.10%-0.99
-1.22%-0.83
35.63%-0.56
-8.57%-0.76
-96.69%-3.56
-15.69%-1.18
45.33%-0.82
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 40.81%2.51M12.96%2.59M-3.47%9.93M-6.79%3.24M9.19%2.61M-27.80%1.78M17.78%2.29M154.50%10.29M84.22%3.48M6.33%2.39M
Selling and administrative expenses -19.86%827K2.37%1.08M-29.00%4.23M-36.23%1.12M-21.81%1.03M-27.07%1.03M-28.68%1.06M184.22%5.96M37.64%1.75M1.21%1.32M
-General and administrative expense -19.86%827K2.37%1.08M-29.00%4.23M-36.23%1.12M-21.81%1.03M-27.07%1.03M-28.68%1.06M184.22%5.96M37.64%1.75M1.21%1.32M
Research and development costs 124.07%1.69M22.02%1.51M31.73%5.7M23.06%2.12M47.03%1.59M-28.79%752K166.16%1.24M122.43%4.32M180.44%1.73M13.33%1.08M
Operating profit -40.81%-2.51M-12.96%-2.59M3.47%-9.93M6.79%-3.24M-9.19%-2.61M27.80%-1.78M-17.78%-2.29M-154.50%-10.29M-84.22%-3.48M-6.33%-2.39M
Net non-operating interest income expense 000-400.00%-3K0-886.16%-5K
Non-operating interest income ----------0--0--0--------100.00%2K--0--0
Non-operating interest expense ----------0--0--0----------5K--0--5K
Other net income (expense) -57.30%79K-14.52%106K209.66%641K21.90%167K139.13%165K780.95%185K720.00%124K3,350.00%207K43,046.71%137K6,912.20%69K
Gain on sale of security -57.30%79K-14.52%106K209.66%641K21.90%167K139.13%165K780.95%185K720.00%124K3,350.00%207K43,046.71%137K6,912.20%69K
Income before tax -52.16%-2.43M-14.53%-2.48M7.87%-9.29M7.97%-3.07M-5.11%-2.45M34.71%-1.6M-10.33%-2.17M-149.89%-10.08M-76.98%-3.34M-3.57%-2.33M
Income tax 0000000000
Net income -52.16%-2.43M-14.53%-2.48M7.87%-9.29M7.97%-3.07M-5.11%-2.45M34.71%-1.6M-10.33%-2.17M-149.89%-10.08M-76.98%-3.34M-3.57%-2.33M
Net income continuous Operations -52.16%-2.43M-14.53%-2.48M7.87%-9.29M7.97%-3.07M-5.11%-2.45M34.71%-1.6M-10.33%-2.17M-149.89%-10.08M-76.98%-3.34M-3.57%-2.33M
Minority interest income
Net income attributable to the parent company -52.16%-2.43M-14.53%-2.48M7.87%-9.29M7.97%-3.07M-5.11%-2.45M34.71%-1.6M-10.33%-2.17M-149.89%-10.08M-76.98%-3.34M-3.57%-2.33M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -52.16%-2.43M-14.53%-2.48M7.87%-9.29M7.97%-3.07M-5.11%-2.45M34.71%-1.6M-10.33%-2.17M-149.89%-10.08M-76.98%-3.34M-3.57%-2.33M
Basic earnings per share -33.93%-0.75-2.63%-0.7811.80%-3.1416.10%-0.99-1.22%-0.8335.63%-0.56-8.57%-0.76-96.69%-3.56-15.69%-1.1845.33%-0.82
Diluted earnings per share -33.93%-0.75-2.63%-0.7811.80%-3.1416.10%-0.99-1.22%-0.8335.63%-0.56-8.57%-0.76-96.69%-3.56-15.69%-1.1845.33%-0.82
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg